Analyst Viewpoint
Increase in prevalence of chronic diseases and technological advancements in analyzers are fueling the blood gas and electrolyte analyzers market size. Blood gas and electrolyte analyzers measure electrolytes, oxygen, carbon dioxide, and the pH of blood.
Rise in demand for early diagnosis of various diseases including diabetes and cancer is driving the demand for blood gas and electrolyte analyzers, thereby fostering market expansion.
Technological advancements in disease diagnosis techniques are offering lucrative blood gas and electrolyte analyzers business opportunities for the companies operating in this sector.
Moreover, key market players are investing in new product launches to enhance their product portfolio and expand their brand presence.
Blood gas and electrolyte analyzers are medical devices used to measure various parameters in blood, including pH, oxygen, and carbon dioxide levels, and electrolytes, such as sodium, potassium, chloride, and other metabolites.
These analyzers play a crucial role in diagnosing and monitoring a wide range of medical conditions, particularly those related to respiratory, renal, and metabolic disorders.
Accuracy and precision, compact and portable design, automated features, quick results, and multi-parameter analysis are some of the major advantages of blood gas and electrolyte analyzers.
Blood gas and electrolyte analyzers are essential tools for healthcare professionals involved in critical care, emergency medicine, anesthesia, and other medical specialties.
| Attribute | Detail |
|---|---|
| Drivers |
|
Blood gas and electrolyte analyzers are used to monitor patient's blood gas levels, electrolyte balance, and acid-base status, essential for managing and treating chronic conditions.
Lack of nutritious diet, physical inactivity, and changing lifestyles are leading to various chronic diseases, such as respiratory disorders, renal diseases, and metabolic disorders.
These conditions require early diagnosis to provide appropriate treatment. Thus, increase in prevalence of chronic diseases is driving the blood gas and electrolyte analyzers market revenue.
According to the World Health Organization, around 41 million fatalities are registered due to Noncommunicable Diseases (NCDs) each year, equivalent to 74% of all deaths globally. Each year, 17 million people die from an NCD before age 70.
Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).
Automated blood gas analyzers in critical care settings are utilized for the diagnosis of these diseases, thereby fueling the blood gas and electrolyte analyzers market statistics.
Medical equipment are developed using advanced technologies to ensure accuracy, reliability, and efficiency. Manufacturers are developing innovative analyzers with improved accuracy, speed, and usability, as well as enhanced connectivity and automation features.
These technological advancements enable healthcare providers to perform quicker and more accurate diagnostic tests, streamline workflow processes, and improve patient care outcomes.
Plasma electrolyte analyzers are developed to perform rapid tests and get accurate test results. Thus, technological advancements in these analyzers are propelling the blood gas and electrolyte analyzers market value.
Moreover, advancements in Point-of-Care Testing (POCT) technologies are driving the adoption of compact, portable analyzers that allow for rapid on-site testing in various healthcare settings, including emergency departments, intensive care units, and ambulances.
Hence, increase in demand for electrolyte and blood gas testing equipment is fostering market development.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the blood gas and electrolyte analyzers industry analysis, North America dominated the global market in 2022. Rise in prevalence of diabetes and rapid growth in geriatric population are likely to drive the blood gas and electrolyte analyzers market share during the forecast period.
Moreover, well-established healthcare infrastructure and easy availability of medical facilities are boosting market progress.
According to the Centers for Disease Control and Prevention, approximately 38.4 million people have diabetes, which accounts for 11.6% of the U.S. population. Moreover, among these, 29.7 million individuals have been diagnosed with diabetes and around 8.7 million people are undiagnosed.
As per the latest blood gas and electrolyte analyzers market trends, advancements in medical facilities and automation in diagnosis technologies generate multiple opportunities for medical equipment manufacturers.
Leading players in the market are forming partnerships and alliances to increase their production capacities and meet consumer demands. Moreover, they are investing to launch new analyzers and ensure result accuracy and reduce diagnosis time.
Some of the players in the industry are Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens Healthineers AG, ERBA Group, Medica Corporation, Abbott, and Werfen, S.A.
These companies have been profiled in the blood gas and electrolyte analyzers market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 2.7 Bn |
| Market Forecast (Value) in 2031 | US$ 5.0 Bn |
| Growth Rate (CAGR) | 6.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.7 Bn in 2022
It is projected to register a CAGR of 6.9% from 2023 to 2031
Increase in prevalence of chronic diseases and technological advancements in blood gas and electrolyte analyzers
North America was the most lucrative region in 2022
Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens Healthineers AG, ERBA Group, Medica Corporation, Abbott, and Werfen, S.A.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Gas and Electrolyte Analyzers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Gas and Electrolyte Analyzers Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Blood Gas and Electrolyte Analyzers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Blood Gas Analyzers
6.3.2. Electrolyte Analyzers
6.3.3. Combination Analyzers
6.3.4. Consumables
6.4. Market Attractiveness Analysis, by Product Type
7. Global Blood Gas and Electrolyte Analyzers Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region, 2017–2031
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Blood Gas and Electrolyte Analyzers Market Analysis and Forecast
8.1. Introduction
8.2. Key Findings
8.3. Market Value Forecast, by Product Type, 2017–2031
8.3.1. Blood Gas Analyzers
8.3.2. Electrolyte Analyzers
8.3.3. Combination Analyzers
8.3.4. Consumables
8.4. Market Value Forecast, by Country, 2017–2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By Country
9. Europe Blood Gas and Electrolyte Analyzers Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product Type, 2017–2031
9.3.1. Blood Gas Analyzers
9.3.2. Electrolyte Analyzers
9.3.3. Combination Analyzers
9.3.4. Consumables
9.4. Market Value Forecast, by Country/Sub-region, 2017–2031
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Country/Sub-region
10. Asia Pacific Blood Gas and Electrolyte Analyzers Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Blood Gas Analyzers
10.3.2. Electrolyte Analyzers
10.3.3. Combination Analyzers
10.3.4. Consumables
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Country/Sub-region
11. Latin America Blood Gas and Electrolyte Analyzers Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Blood Gas Analyzers
11.3.2. Electrolyte Analyzers
11.3.3. Combination Analyzers
11.3.4. Consumables
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Country/Sub-region
12. Middle East & Africa Blood Gas and Electrolyte Analyzers Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Blood Gas Analyzers
12.3.2. Electrolyte Analyzers
12.3.3. Combination Analyzers
12.3.4. Consumables
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
13.2. Market Share Analysis, by Company (2022)
13.3. Company Profiles
13.3.1. Radiometer Medical ApS
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. F. Hoffmann-La Roche Ltd.
13.3.2.1. Company Overview
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. Nova Biomedical
13.3.3.1. Company Overview
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Siemens Healthineers AG
13.3.4.1. Company Overview
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. ERBA Group
13.3.5.1. Company Overview
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Medica Corporation
13.3.6.1. Company Overview
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Abbott
13.3.7.1. Company Overview
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. Werfen, S.A.
13.3.8.1. Company Overview
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
List of Tables
Table 01: Global Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 03: North America Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 04: North America Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 05: Europe Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 06: Europe Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: Asia Pacific Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Asia Pacific Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: Latin America Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Latin America Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
List of Figures
Figure 01: Global Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Blood Gas and Electrolyte Analyzers Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Blood Gas and Electrolyte Analyzers Market Value Share, by Product Type, 2022
Figure 04: Global Blood Gas and Electrolyte Analyzers Market Value Share, by Region, 2022
Figure 05: Global Blood Gas and Electrolyte Analyzers Market Value (US$ Mn) Forecast, 2017–2031
Figure 06: Global Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 07: Global Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 08: Global Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Region, 2022–2031
Figure 09: Global Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America Blood Gas and Electrolyte Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 11: North America Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Country, 2023–2031
Figure 12: North America Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Country, 2022–2031
Figure 13: North America Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 14: North America Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 15: Europe Blood Gas and Electrolyte Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 16: Europe Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 17: Europe Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 18: Europe Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 19: Europe Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 20: Asia Pacific Blood Gas and Electrolyte Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 21: Asia Pacific Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 22: Asia Pacific Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 23: Asia Pacific Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 24: Asia Pacific Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 25: Latin America Blood Gas and Electrolyte Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 26: Latin America Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 27: Latin America Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 28: Latin America Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 29: Latin America Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 30: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 31: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 32: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 33: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Value Share Analysis, by Product Type, 2022–2031
Figure 34: Middle East & Africa Blood Gas and Electrolyte Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blood Gas and Electrolyte Analyzers Market
